Nociceptin/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice
Nikol Sullo(Institute for Experimental Endocrinology and Oncology), Bruno D’Agostino(University of Naples - L'Orientale), Giuseppe Spaziano(University of Campania "Luigi Vanvitelli"), Angela Ianaro(University of Naples Federico II), Remo Guerrini(University of Ferrara), Fiorentina Roviezzo(University of Naples Federico II), Luana De Gruttola(University of Naples Federico II), Francesco Rossi(Institute for Experimental Endocrinology and Oncology), Giuseppe Cirino(University of Naples Federico II), Maria Matteis(University of Padua), Girolamo Calò(University of Padua)
American Journal of Physiology-Lung Cellular and Molecular Physiology
March 16, 2013
Cited by 23
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
|Pharmacological Reviews|2016|290